Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Egyptian Liver Journal. 2018; 8 (1): 29-35
in English | IMEMR | ID: emr-199915

ABSTRACT

Background Laparoscopic sleeve gastrectomy [LSG] is a recently developed technique for treating morbid obesity. As it is a simple procedure, many bariatric surgeons have adopted it in recent years with good results. LSG is a purely gastric restrictive procedure designed to reduce appetite by decreasing the size of the stomach


Objectives The aim of this study was to investigate the metabolic outcomes of LSG, including rate of weight loss, amelioration of obesity-related comorbidities as well as the intraoperative and postoperative complications


Patients and methods From August 2011 to August 2013, 60 consecutive patients with morbid obesity [eight males and 52 females] underwent laparoscopic sleeve gastrectomy at the Ain Shams University Hospital [El-Demerdash] and Ain Shams Specialized Hospital. Follow-up of the patients was done for a period of 2 years to investigate the preliminary results of this procedure including operative morbidity and mortality, short-term and long-term complications, rates and parameters of weight loss, as well as the effect on lipid and energy metabolism


Results There were two cases [2/60 [3.3%]] with intra-abdominal bleeding following LSG. Staple-line failure was detected in two cases [2/60 [3.3%]], two early complications [2/60 [3.3%]] were encountered, and late complications occurred in two patients [2/30 [3.3%]], with no mortality occurred. Substantial weight loss occurred in all patients. Mean excess weight loss was 48.04+/-4.34% at the end of first year and 67.85+/-3.75% at the end of the second year. Complete resolution of comorbidities was 73.3% for hypertension and 80% for diabetes mellitus at the end of second year


Conclusion LSG is a feasible and safe restrictive bariatric procedure, with good short-term results. It offers the advantages of a simple and reproducible technique with good outcome and low morbidity and mortality. LSG is accepted as a standalone definitive therapy, as it has a high percentage of postoperative excess weight loss as well as reduction of obesity-related comorbidities

SELECTION OF CITATIONS
SEARCH DETAIL